Transcode Therapeutics Inc (RNAZ) — Defensive Interval Ratio
Transcode Therapeutics Inc (RNAZ) has a Defensive Interval Ratio of 340 days as of March 2026. Defensive assets of $3.25 Million (cash $-, short-term investments $-, receivables $3.25 Million) cover 340 days of daily cash needs of $9.57K/day. Check RNAZ tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Transcode Therapeutics Inc Defensive Interval Ratio (2020–2025)
This chart shows how Transcode Therapeutics Inc's Defensive Interval Ratio has evolved across 4 annual periods from 2020 to 2025. As of March 2026, the ratio stands at 340 days, meaning defensive assets of $3.25 Million can fund 340 days of operations without new revenue. Also explore how fast is Transcode Therapeutics Inc growing its equity to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Transcode Therapeutics Inc (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Transcode Therapeutics Inc from 2020 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Transcode Therapeutics Inc market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 340 days | $3.25 Million | $9.57K/day | $- | $- | ▲ +309 days |
| 2022 | 31 days | $369.64K | $11.91K/day | $- | $9.41K | ▲ +31 days |
| 2021 | 0 days | $9.41 | $6.94K/day | $- | $9.41 | ▼ 0 days |
| 2020 | 0 days | $3.20 | $1.11K/day | $- | $3.20 | — |